X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs SUVEN LIFESCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB SUVEN LIFESCIENCES UNICHEM LAB/
SUVEN LIFESCIENCES
 
P/E (TTM) x 289.7 20.7 1,399.8% View Chart
P/BV x 0.7 3.9 17.1% View Chart
Dividend Yield % 2.5 0.6 434.3%  

Financials

 UNICHEM LAB   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
SUVEN LIFESCIENCES
Mar-18
UNICHEM LAB/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs382251 152.3%   
Low Rs234155 151.0%   
Sales per share (Unadj.) Rs116.349.1 236.7%  
Earnings per share (Unadj.) Rs-18.99.7 -194.7%  
Cash flow per share (Unadj.) Rs-11.711.4 -103.1%  
Dividends per share (Unadj.) Rs5.001.50 333.3%  
Dividend yield (eoy) %1.60.7 219.6%  
Book value per share (Unadj.) Rs381.060.3 631.9%  
Shares outstanding (eoy) m70.34127.28 55.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.64.1 64.1%   
Avg P/E ratio x-16.320.9 -78.0%  
P/CF ratio (eoy) x-26.217.8 -147.3%  
Price / Book Value ratio x0.83.4 24.0%  
Dividend payout %-26.415.4 -171.2%   
Avg Mkt Cap Rs m21,66825,825 83.9%   
No. of employees `0002.31.1 212.7%   
Total wages/salary Rs m2,006613 327.5%   
Avg. sales/employee Rs Th3,587.85,832.6 61.5%   
Avg. wages/employee Rs Th880.0571.5 154.0%   
Avg. net profit/employee Rs Th-583.71,153.8 -50.6%   
INCOME DATA
Net Sales Rs m8,1806,253 130.8%  
Other income Rs m610233 262.2%   
Total revenues Rs m8,7906,485 135.5%   
Gross profit Rs m-1,3201,982 -66.6%  
Depreciation Rs m505213 237.0%   
Interest Rs m8046 173.0%   
Profit before tax Rs m-1,2951,955 -66.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m33718 4.7%   
Profit after tax Rs m-1,3311,237 -107.6%  
Gross profit margin %-16.131.7 -50.9%  
Effective tax rate %-2.636.7 -7.0%   
Net profit margin %-16.319.8 -82.3%  
BALANCE SHEET DATA
Current assets Rs m23,3185,622 414.7%   
Current liabilities Rs m4,6351,168 397.0%   
Net working cap to sales %228.471.2 320.6%  
Current ratio x5.04.8 104.5%  
Inventory Days Days12281 149.5%  
Debtors Days Days12136 338.1%  
Net fixed assets Rs m8,1633,325 245.5%   
Share capital Rs m141127 110.5%   
"Free" reserves Rs m26,6607,547 353.3%   
Net worth Rs m26,8017,674 349.2%   
Long term debt Rs m314 23.7%   
Total assets Rs m31,8909,135 349.1%  
Interest coverage x-15.243.2 -35.1%   
Debt to equity ratio x00 6.8%  
Sales to assets ratio x0.30.7 37.5%   
Return on assets %-3.914.0 -27.9%  
Return on equity %-5.016.1 -30.8%  
Return on capital %-4.526.0 -17.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,3565,066 86.0%   
Fx outflow Rs m02,001 0.0%   
Net fx Rs m4,3563,065 142.1%   
CASH FLOW
From Operations Rs m-1,123699 -160.6%  
From Investments Rs m16,487-6 -270,273.8%  
From Financial Activity Rs m-8,811-577 1,527.1%  
Net Cashflow Rs m6,552116 5,633.7%  

Share Holding

Indian Promoters % 50.1 63.4 79.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 36.5 86.8%  
Shareholders   20,176 37,287 54.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   AJANTA PHARMA  GLENMARK PHARMA  SHASUN PHARMA  STRIDES PHARMA SCIENCE  FDC LTD.  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and Energy Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector.

Related Views on News

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

The Jet Airways Crisis in 6 Charts(Sector Info)

Mar 5, 2019

What happened to Jet Airways, once among top 3 airlines in India? Is it another Kingfisher in the making? Read on...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Mar 18, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS